Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|August 29, 2021
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 studyJong-Mu Sun, Lin Shen, Manish A Shah, et al.
The Lancet. Oncology|February 6, 2019
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trialCharles S Fuchs, Kohei Shitara, Maria Di Bartolomeo, et al.
JCO Precision Oncology|September 14, 2020
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical TrialsRodrigo Dienstmann, Elena Garralda, Susana Aguilar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO StudyMaria Alsina, Guillermo Villacampa, Carlos de Andrea, et al.
JAMA Oncology|September 4, 2020
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical TrialKohei Shitara, Eric Van Cutsem, Yung-Jue Bang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the EsophagusLucjan Wyrwicz, Arunee Dechaphunkul, Jong-Seok Lee, et al.
Therapeutic Advances in Medical Oncology|July 2, 2021
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registryPaula Jimenez-Fonseca, Alberto Carmona-Bayonas, Alba Martinez-Torron, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 12, 2025
Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe: A Strategy Proposed by the LEGACy ConsortiumJuan Antonio Carbonell-Asins, Elena Jiménez-Martí, Sergio Romero, et al.
Cancer Discovery|January 30, 2013
First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvementJosep Tabernero, Geoffrey I Shapiro, Patricia M LoRusso, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 2, 2021
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM RegistryFelipe Alvarez-Manceñido, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, et al.
Pageof 8